Covaxin is effective against UK variant of coronavirus: ICMR study
PTI, Jan 28, 2021, 4:17 PM IST
Covaxin is effective against the new variant of COVID-19 that was traced in the UK, an ICMR study has said. “Covaxin, developed by Bharat Biotech with ICMR, has equivalent immunogenicity against the UK-variant and circulating strains of SARS-COV-2 in India,” tweeted ICMR.
“It’s reassuring the vaccine can work against the new UK variant,” said ICMR Director General Dr Balram Bhargava.
As reported by Indian Express, While the data collected from 38 people looks promising, there is no clarity on the vaccine’s efficacy yet, as it is being administered to priority groups in “clinical trial” mode. Greater clarity is expected to emerge later this year, when Bharat Biotech will have enough information to say how effective the vaccine is in preventing those inoculated from showing serious symptoms, even if they do get infected.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Why not detect sex of foetus, then protect girl child: IMA chief Asokan
Include 4 hrs of physical activity, 8 hrs sleep in routine for optimal health, suggests study
Traffic noise can increase risk of cardiovascular disease: Study
Nearsightedness is at epidemic levels – and the problem begins in childhood
Study finds genetic basis for link between depression, heart disease
MUST WATCH
Latest Additions
SC questions ED on timing of Kejriwal’s arrest, seeks its reply
Nadda holds roadshow in Karnataka’s Haveri
Markets wipe out early gains on fag-end sell-off; Nifty slips from record
We don’t send dossiers on terror; ‘Bharat ghar mein ghus ke marta hai’: PM Modi
Cricket: India’s T20 World Cup squad announced